Receptors for advanced glycation end products is associated with autophagy in the clear cell renal cell carcinoma

J Cancer Res Ther. 2019;15(2):317-323. doi: 10.4103/jcrt.JCRT_180_18.

Abstract

Background: The receptor for advanced glycation end-product (RAGE) was one of the signal transduction receptors. RAGE interacted with various signaling molecules which were involved in human disease processes including tumorigenesis. Previous reports have indicated that RAGE/high-mobility group box 1 (HMGB1) could regulate autophagy in different carcinomas. However, the functional role of RAGE/ HMGB1 in the regulation of clear cell renal cell carcinoma (ccRCC) autophagy remained unrevealed.

Methods: Western blot, quantitative real-time polymerase chain reaction (qRT-PCR) and immunofluorescence were used in the present study.

Results: In this study, we demonstrated that the levels of RAGE/HMGB1 and autophagic protein LC3, Beclin-1, PI3K were much higher in ccRCC samples than those of in adjacent normal tissues. RAGE and autophagic protein expression was regulated with RAGE/HMGB1 in human RCC cell lines.

Conclusion: Our results implicated that RAGE and autophagy played important roles in ccRCC, and RAGE/HMGB1 might serve as a novel therapeutic target for future ccRCC treatment.

Keywords: Autophagy; clear cell renal cell carcinoma; high-mobility group box 1; receptor for advanced glycation end-product.

MeSH terms

  • Autophagy*
  • Biomarkers
  • Carcinoma, Renal Cell / metabolism*
  • Carcinoma, Renal Cell / pathology
  • HMGB1 Protein / metabolism
  • Humans
  • Kidney Neoplasms / metabolism*
  • Kidney Neoplasms / pathology
  • Microtubule-Associated Proteins / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Receptor for Advanced Glycation End Products / metabolism*

Substances

  • AGER protein, human
  • Biomarkers
  • HMGB1 Protein
  • MAP1LC3A protein, human
  • Microtubule-Associated Proteins
  • Receptor for Advanced Glycation End Products